Finance

Beta
Lists
SXTPW:NASDAQ
60 Degrees Pharmaceuticals
$0.039
-0.77%
(-0.00030) 1D
Jun 10, 10:25:40 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SXTPW...
Mkt. cap
3.67M
Avg. vol.
2.19K
Volume
0.00
52-wk high
$0.16
52-wk low
$0.03
No. of employees
3
Mkt. cap
3.67M
Avg. vol.
2.19K
Volume
0.00
52-wk high
$0.16
52-wk low
$0.03
No. of employees
3
News stories
From sources across the web
About 60 Degrees Pharmaceuticals
CEO-
Employees3
Founded2010
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
307.87K
528.56K
316.38K
162.09K
Cost of goods sold
299.94K
1.35M
759.56K
367.18K
Cost of revenue
299.94K
1.35M
759.56K
367.18K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.61M
1.51M
1.47M
1.89M
Operating expense
1.61M
1.51M
1.47M
1.89M
Total operating expenses
1.91M
2.85M
2.23M
2.26M
Operating income
-1.60M
-2.33M
-1.92M
-2.09M
Other non operating income
-127.38K
10.45K
479.57K
6.20K
EBT including unusual items
-1.73M
-2.32M
-1.44M
-2.09M
EBT excluding unusual items
-1.73M
-2.32M
-1.44M
-2.09M
Income tax expense
1.50K
250.00
-1.81K
-
Effective tax rate
-0.09%
-0.01%
0.13%
-
Other operating expenses
-
-
-
-
Net income
-1.73M
-2.32M
-1.44M
-2.09M
Net profit margin
-563.13%
-438.23%
-454.69%
-1,288.91%
Earnings per share
-4.33
-2.53
-8.17
-1.21
Interest and investment income
-
-
-
-
Interest expense
-1.22K
-1.71K
-3.09K
-1.39K
Net interest expenses
-1.22K
-1.71K
-3.09K
-1.39K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.59M
-2.30M
-1.89M
-2.07M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more